Company Information
USD
20.29
- (-3%)
NASDAQ:SNDX, SYNDAX PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 17 May 2024 GMT-4
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
Address
35 Gatehouse Drive
Building D, Floor 3
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Dennis G. Podlesak
Director/Chairman of the Board
Mr. Keith A. Katkin
Director
Mr. Pierre Legault, C.P.A.,M.B.A.
Director
Mr. Michael A. Metzger
CEO/Director
Mr. Keith A. Goldan
CFO/Chief Accounting Officer/Treasurer
Mr. William Meury
Director
Dr. Briggs W. Morrison, M.D.
Director
Dr. Martin H. Huber, M.D.
Director
Ms. Jennifer Ann Jarrett
Director
Dr. Neil Gallagher, M.D.
Other Corporate Officer/President
Mr. Peter Ordentlich
Chief Scientific Officer/Co-Founder
Mr. Luke J. Albrecht
General Counsel/Secretary/Senior VP
Ms. Catherine Madigan
Chief Medical Officer
Ms. Anjali Ganguli, PhD
Other Executive Officer
Mr. Steve M. Sabus
Other Executive Officer
Ownership
Institution Holdings
Wellington Management Company LLP
7,585,221 (8.927%)
Wellington Management Group, LLP
7,585,221 (8.927%)
BlackRock Inc
7,015,548 (8.257%)
Kynam Capital Management, LP
5,660,000 (6.662%)
State Street Corporation
5,016,224 (5.904%)
Vanguard Group Inc
4,335,353 (5.102%)
venBio Select Advisor LLC
4,222,222 (4.969%)
Avidity Partners Management LP
3,950,000 (4.649%)
SSGA Funds Management Inc
3,817,038 (4.492%)
Eversept Partners, LLC
3,383,244 (3.982%)
Funds Holdings
Vanguard Health Care Fund
4,249,352 (5.001%)
SPDR® S&P Biotech ETF
3,787,831 (4.458%)
Vanguard US Total Market Shares ETF
2,404,279 (2.830%)
Vanguard Total Stock Market Index Fund
2,404,279 (2.830%)
iShares Russell 2000 ETF
1,655,372 (1.948%)
Vanguard Institutional Extnd Mkt Idx Tr
1,130,195 (1.330%)
T. Rowe Price Small-Cap Value Fund
878,100 (1.033%)
Wellington Global Health Care Equity
815,506 (0.960%)
Fidelity Small Cap Index Fund
665,125 (0.783%)
iShares Biotechnology ETF
584,228 (0.688%)
Make Smart Investment Choices